MPTP-induced parkinsonism in monkeys: Mechanism of action, selectivity and pathophysiology

This publication has 91 references indexed in Scilit:

• ALZHEIMER'S DISEASE, PARKINSON'S DISEASE, AND MOTONEURONE DISEASE: ABIOTROPIC INTERACTION BETWEEN AGEING AND ENVIRONMENT?
  The Lancet, 1986
• Saccadic eye movement deficits in the MPTP monkey model of Parkinson's disease
  Brain Research, 1986
• Hemiparkinsonism in monkeys after unilateral internal carotid artery artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
  Life Sciences, 1986
• Positron emission tomography after MPTP: observations relating to the cause of Parkinson's disease
  Nature, 1985
• Permanent human parkinsonism due to 1‐methy 1–4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)
  Neurology, 1985
• Increased life expectancy resulting from addition of l-deprenyl to Madopar® treatment in Parkinson's disease: A longterm study
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1985
• New amphibian models for the study of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
  Life Sciences, 1985
• Pharmacology of dopamine neurons innervating the prefrontal, cingulate and piriform cortices
  European Journal of Pharmacology, 1983
• The mesolimbic dopamine system: Evidence for a high amine turnover and for a heterogeneity of the dopamine neuron population
  Neuroscience Letters, 1980
• Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlations
  Journal of the Neurological Sciences, 1973